Biopharmaceuticals
Cardiology
FDA
News Release - September 24, 2007
FDA Accepts sNDA for Expanded Use of Angiomax(R) (bivalirudin)
Source: The Medicines Company
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.